Effect of interferon on a nonenveloped DNA virus (TT virus) associated with acute and chronic hepatitis of unknown etiology

Journal of Medical Virology

Volumn 58, Issue 3, 1999, Pages 196-200

  Akahane, Yoshihiro ^a   Sakamoto, Minoru ^a   Miyazaki, Yoshiki ^a   Okada, Shunichi ^a   Inoue, Taisuke ^a   Ukita, Masato ^b   Okamoto, Hiroaki ^b   Miyakawa, Yuzo ^c   Mayumi, Makoto ^b  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Miyakawa Memorial Research Foundation   (Japan)

Author keywords

Chronic hepatitis; Hepatitis C virus; Hepatitis viruses; Interferons

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON;

ACUTE HEPATITIS; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; DNA VIRUS; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEPATITIS C VIRUS; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; RISK FACTOR; SUPERINFECTION; VIRUS DETECTION; VIRUS TITRATION;

ACUTE DISEASE; ADULT; AGED; ANTIVIRAL AGENTS; DNA VIRUS INFECTIONS; DNA VIRUSES; DNA, VIRAL; FEMALE; FLAVIVIRIDAE; HEPACIVIRUS; HEPATITIS; HEPATITIS C, CHRONIC; HEPATITIS, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; INTERFERONS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0033067876     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199907)58:3<196::AID-JMV2>3.0.CO;2-L     Document Type: Article

References (27)

1. Alter HJ. 1997. G-pers creepers, where'd you get those papers?: a reassessment of the literature on the hepatitis G virus. Transfusion 37:569-572.
2. Alter HJ, Bradley DW. 1995. Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC). Semin Liver Dis 15:110-120.
3. Benvegnu L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, Alberti A. 1994. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Cancer 74:2442-2448.
4. Cavanaugh VJ, Guidotti LG, Chisari FV. 1998. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J Virol 72:2630-2637.
5. Charlton M, Adjei P, Poterucha J, Zien N, Moore B, Therneau T, Krom R, Wiesner R. 1998. TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology 28:839-842.
6. De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, Scheuer PJ, Schmid M, Thaler H, Uehlinger E. 1968. A classification of chronic hepatitis. Lancet 2:626-628.
7. Fujiwara T, Iwata A, Iizuka H, Tanaka T, Okamoto H. 1998. Transfusion transmitted virus. (Correspondence). Lancet 352:1310.
8. Hino K, Sainokami S, Shimoda K, Iino S, Wang Y, Okamoto H, Miyakawa Y, Mayumi M. 1994. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 42:299-305.
9. Inoue T, Sakamoto M, Akahane Y, Okamoto H, Miyakawa Y, Mayumi M. 1997. Response to interferon of GB virus C and hepatitis C virus in patients with chronic hepatitis. Am J Gastroenterol 92: 1981-1985.
10. Kaklamani E, Trichopoulos D, Tzonou A, Zavitsanos X, Koumantaki Y, Hatzakis A, Hsieh CC, Hatziyannis S. 1991. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 265:1974-1976.
11. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. 1981. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435.
12. Kodali VP, Gordon SC, Silverman AL, McCray DG. 1994. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis. Am J Gastroenterol 89:1836-1839.
13. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Desai SM, Mushahwar IK. 1996. Sequence and genomic organization of GBV-C: A novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Virol 48:60-67.
14. Linnen J, Wages J, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayiannis P, Fung K, Nakatsuji Y, Shin JWK, Young L, Piatak M, Hoover C, Fernandez J, Chen S, Zou JC, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Foung SKH, Thomas H, Bradley D, Margolis H, Kim JP. 1996. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271:505-508.
15. Miyakawa Y, Mayumi M. 1997. Hepatitis G virus: a true hepatitis virus or an accidental tourist? N Engl J Med 336:786-787.
16. Naoumov NV, Petrova EP, Thomas MG, Williams R. 1998. Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet 352:195-197.
17. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. 1997. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 241:92-97.
18. Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M. 1990. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 64:1298-1303.
19. Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda H, Iizuka H, Miyakawa Y, Mayumi M. 1998a. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res 10:1-16.
20. Okamoto H, Akahane Y, Ukita M, Fukuda M, Tsuda F, Miyakawa Y, Mayumi M. 1998b. Fecal excretion of a non-enveloped DNA virus (TTV) associated with posttransfusion non-A to G hepatitis. J Med Virol 56:128-139.
21. Pessoa MG, Terrault NA, Detmer J, Kolberg J, Collins M, Hassoba HM, Wright TL. 1998. Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic. Hepatology 27:877-880.
22. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, Alberti A. 1993. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 105:1529-1533.
23. Simmonds P, Davidson F, Lycett C, Prescott LE, MacDonald DM, Ellender J, Yap PL, Ludlam CA, Haydon GH, Gillon J, Jarvis LM. 1998. Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet 352:191-195.
24. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK. 1995. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1:564-569.
25. Tanaka H, Okamoto H, Luengrojanakul P, Chainuvati T, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M. 1998. Infection with an unenveloped DNA virus (TTV) associated with posttransfusion non-A to G hepatitis in hepatitis patients and healthy blood donors in Thailand. J Med Virol 56:234-238.
26. Wright TL. 1993. Etiology of fulminant hepatic failure: is another virus involved? Gastroenterology 104:640-643.
27. Zuckerman AJ. 1995. The new GB hepatitis viruses. Lancet 345: 1453-1454.